EI
EXAS

Ethic Inc’s Exact Sciences EXAS Stock Holding History

Ethic Inc’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,882
Closed -$274K – 1193
2024
Q4 		$274K Sell
4,882
-1,015
-17% -$63.2K 0.01% 964
2024
Q3 		$407K Buy
+5,897
New +$333K 0.01% 809
2024
Q2 		– Sell
-5,897
Closed -$407K – 1147
2024
Q1 		$407K Sell
5,897
-149
-2% -$9.43K 0.01% 809
2023
Q4 		$447K Sell
6,046
-4,549
-43% -$298K 0.01% 771
2023
Q3 		$723K Buy
10,595
+2,069
+24% +$176K 0.03% 564
2023
Q2 		$801K Sell
8,526
-1,612
-16% -$126K 0.03% 506
2023
Q1 		$687K Buy
10,138
+4,466
+79% +$287K 0.03% 559
2022
Q4 		$281K Buy
+5,672
New +$232K 0.02% 740

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ethic Inc's EXAS Position: Q1 2025 in Review

Ethic Inc sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 4,882 shares — an estimated $274K sold.

Ethic Inc first reported a position in EXAS in Q4 2022 and held it in 8 quarters. The position peaked at $801K in Q2 2023. 557 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • Ethic Inc reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • Ethic Inc sold 4,882 Exact Sciences shares in Q1 2025, an estimated $274K.
  • Ethic Inc first reported a position in Exact Sciences in Q4 2022 and held it in 8 quarters.
  • Ethic Inc's Exact Sciences position peaked at $801K in Q2 2023.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on Ethic Inc's 13F filing for Q1 2025, filed 13 May 2025.